Cannabis use during pregnancy may alter placental and fetal DNA methylation (the process of turning genes “on” and “off”) in ways that increase the likelihood of autism spectrum disorder (ASD) or other neurobehavioral conditions, according to a new study.
Lyndsey Shorey-Kendrick and colleagues, who conducted the study, say, “Cannabis use among pregnant individuals, especially during the critical developmental window in the first trimester to mitigate morning sickness symptoms, has doubled in the past decade, and half of those that use cannabis will continue to use throughout pregnancy.” They add that while research is limited, “[S]tudies suggest adverse effects of prenatal cannabis exposure that include preterm birth, stillbirth, and small for gestational age infants. Maternal cannabis use has also been associated with an increased risk for neurobehavioral morbidity in human offspring, including ASD, attention deficit hyperactivity disorder (ADHD), intellectual disability and learning disorders, and other neuropsychiatric disorders.”
To explore the effects of cannabis exposure in utero, Shorey-Kendrick and colleagues studied pregnant rhesus macaques. Half of the animals received a daily edible of THC (the active ingredient in cannabis), while the other half received a placebo. The researchers found that THC exposure altered fetal and placental methylation, causing significant changes involving genes associated with neurobehavioral disorders, including ASD.
Study coauthor Jamie Lo, who notes that “it’s not common practice for providers to discuss cannabis use with patients who are pregnant or trying to conceive,” says the researchers hope their findings will open up a broader dialog about the potential effects of cannabis use during preconception and the prenatal period.
—
“Prenatal delta-9-tetrahydrocannabinol exposure is associated with changes in rhesus macaque DNA methylation enriched for autism genes,” Lyndsey E. Shorey-Kendrick, Victoria H. J. Roberts, Rahul J. D’Mello, Elinor L. Sullivan, Susan K. Murphy, Owen J. T. Mccarty, Danny J. Schust, Jason C. Hedges, A. J. Mitchell, Jose Juanito D. Terrobias, Charles A. Easley IV, Eliot R. Spindel, and Jamie O. Lo, Clinical Epigenetics, July 6, 2023 (free online). Address: Lyndsey Shorey-Kendrick, Division of Neuroscience, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, 97006, [email protected].
—and—
“THC use during pregnancy linked to changes in fetal development,” news release, Nicole Rideout, Oregon Health & Science University, July 6, 2023.
This article originally appeared in Autism Research Review International, Vol. 36, No. 3, 2023
Editorial: What we breathe matters – Rethinking air pollution and autism
For nearly sixty years, the Autism Research Institute (ARI) has tried to understand autism by looking beyond surface behaviors and asking deeper biological questions. From the beginning, Bernard Rimland challenged the dominant
Editorial: Invisible threats – the role of environmental toxins in autism
As our knowledge about autism continues to evolve, so does our understanding of its root causes. For many years, professionals blamed “refrigerator parents” and prescribed psychoanalytic therapy. Once the psychogenic theory was
ARI’s 2025 Impact
Advocating for Independent Research and Education For nearly six decades, ARI has funded groundbreaking research, expanded educational initiatives, and brought clinicians and scientists together worldwide. Yet researchers and clinicians continue to face unprecedented